Abstract CT189: Improved progression-free and overall survival (PFS/OS) in patients (pts) with emergence of JTX-2011 associated biomarker (ICOS high CD4 T cells) on the ICONIC trial
Year: 2019
Type: conference-abstract
Source: Clinical Trials
Authors: Timothy Anthony Yap, Justin F. Gainor, Margaret K. Callahan, Gerald S. Falchook, Russell Kent Pachynski, Patricia LoRusso, Shivaani Kummar, Geoffrey Thomas Gibney, Howard A. Burris, Scott S. Tykodi, Osama E. Rahma, Tanguy Seiwert, Kyriakos P. Papadopoulos, Ellen Hooper, Christopher J. Harvey, Amanda Hanson, Sean Lacey, Rachel McComb, Courtney Hart, Haley Laken, Ty McClure, Elizabeth Trehu
Institutions: The University of Texas MD Anderson Cancer Center, Massachusetts General Hospital, Memorial Sloan Kettering Cancer Center, Washington University in St. Louis, Yale Cancer Center, Stanford University, Sarah Cannon, Seattle Cancer Care Alliance, Dana-Farber Cancer Institute, University of Chicago, South Texas Accelerated Research Therapeutics, Jounce Therapeutics (United States)
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4246684695